L.E.M laboratory participated in the ISCORT convention in Eilat, presnting Prosigna-PAM50 gene

signature providing breast tumor patients identification of tumor subtype, and risk of recurrence of 10 years.

L.E.M is the only laboratory in Israel providing the test under supervision of the Israeli ministry of health. 

For more information regarding breast tumor gene signature pleast press here